Results 91 to 100 of about 1,968,036 (106)
Objectives Immune-mediated necrotizing myopathy (IMNM) with autoantibodies targeting 3-hydroxy-3-methylglutaryl-CoA reductase (anti-HMGCR) is considered a rare complication of statin therapy.
Brusch, Anna +13 more
core
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Rituximab use for refractory anti-HMGCR immune-mediated necrotizing myopathy: A case report
Intractable and Rare Diseases Research, 2021Sonia Gupta
exaly
Alanine transaminase is predominantly increased in the active phase of anti-HMGCR myopathy
Neuromuscular Disorders, 2022Ran Nakashima +2 more
exaly
Necrotizing myopathy with elevated anti-HMGCR antibodies following exposure to the supplement Bacopa
Muscle and Nerve, 2023Maxwell Greene +2 more
exaly
Anti-HMGCR myopathy following acute Epstein–Barr virus infection
Muscle and Nerve, 2020Ichizo Nishino +2 more
exaly
Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China
Journal of Clinical Neuroscience, 2018Wen-Hua Zhu, Chong-Bo Zhao
exaly

